Mediwelcome Healthcare Management & Technology Inc.

Informe acción SEHK:2159

Capitalización de mercado: HK$79.0m

Mediwelcome Healthcare Management & Technology Dirección

Dirección controles de criterios 4/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Liang Wang

Chief Executive Officer (CEO)

CN¥691.0k

Compensación total

Porcentaje del salario del CEO86.8%
Permanencia del CEO5.2yrs
Participación del CEO6.0%
Permanencia media de la dirección5.2yrs
Promedio de permanencia en la Junta Directiva4.5yrs

Actualizaciones recientes de la dirección

Recent updates

There's No Escaping Mediwelcome Healthcare Management & Technology Inc.'s (HKG:2159) Muted Revenues Despite A 25% Share Price Rise

Oct 03
There's No Escaping Mediwelcome Healthcare Management & Technology Inc.'s (HKG:2159) Muted Revenues Despite A 25% Share Price Rise

Mediwelcome Healthcare Management & Technology Inc. (HKG:2159) Surges 28% Yet Its Low P/S Is No Reason For Excitement

Jun 18
Mediwelcome Healthcare Management & Technology Inc. (HKG:2159) Surges 28% Yet Its Low P/S Is No Reason For Excitement

Improved Revenues Required Before Mediwelcome Healthcare Management & Technology Inc. (HKG:2159) Shares Find Their Feet

Mar 06
Improved Revenues Required Before Mediwelcome Healthcare Management & Technology Inc. (HKG:2159) Shares Find Their Feet

There's No Escaping Mediwelcome Healthcare Management & Technology Inc.'s (HKG:2159) Muted Revenues

Aug 15
There's No Escaping Mediwelcome Healthcare Management & Technology Inc.'s (HKG:2159) Muted Revenues

Mediwelcome Healthcare Management & Technology (HKG:2159) Might Be Having Difficulty Using Its Capital Effectively

Aug 12
Mediwelcome Healthcare Management & Technology (HKG:2159) Might Be Having Difficulty Using Its Capital Effectively

Calculating The Intrinsic Value Of Mediwelcome Healthcare Management & Technology Inc. (HKG:2159)

Apr 08
Calculating The Intrinsic Value Of Mediwelcome Healthcare Management & Technology Inc. (HKG:2159)

Some Investors May Be Worried About Mediwelcome Healthcare Management & Technology's (HKG:2159) Returns On Capital

Jan 24
Some Investors May Be Worried About Mediwelcome Healthcare Management & Technology's (HKG:2159) Returns On Capital

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Liang Wang en comparación con los beneficios de Mediwelcome Healthcare Management & Technology?
FechaCompensación totalSalarioIngresos de la empresa
Jun 30 2024n/an/a

-CN¥81m

Mar 31 2024n/an/a

-CN¥87m

Dec 31 2023CN¥691kCN¥600k

-CN¥94m

Sep 30 2023n/an/a

-CN¥86m

Jun 30 2023n/an/a

-CN¥79m

Mar 31 2023n/an/a

-CN¥84m

Dec 31 2022CN¥2mCN¥570k

-CN¥89m

Sep 30 2022n/an/a

-CN¥57m

Jun 30 2022n/an/a

-CN¥26m

Mar 31 2022n/an/a

-CN¥11m

Dec 31 2021CN¥3mCN¥650k

CN¥5m

Sep 30 2021n/an/a

CN¥6m

Jun 30 2021n/an/a

CN¥8m

Mar 31 2021n/an/a

CN¥14m

Dec 31 2020CN¥662kCN¥600k

CN¥21m

Sep 30 2020n/an/a

CN¥19m

Jun 30 2020n/an/a

CN¥16m

Mar 31 2020n/an/a

CN¥18m

Dec 31 2019CN¥665kCN¥573k

CN¥21m

Compensación vs. Mercado: La compensación total de Liang($USD95.43K) está por debajo de la media de empresas de tamaño similar en el mercado Hong Kong ($USD233.11K).

Compensación vs. Ingresos: La compensación de Liang ha sido consistente con los resultados de la empresa en el último año.


CEO

Liang Wang (48 yo)

5.2yrs

Permanencia

CN¥691,000

Compensación

Mr. Liang Wang serves as the Chief Executive Officer at Mediwelcome Healthcare Management & Technology Inc. and has been its Executive Director since September 18, 2019. Mr. Wang co-founded Mediwelcome Gro...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Wei Shi
Executive Chairman of the Board5.8yrsCN¥691.00k20.33%
HK$ 16.1m
Liang Wang
CEO & Executive Directorno dataCN¥691.00k6.02%
HK$ 4.8m
Weimin Yang
Executive Vice Chairman of the Board5.2yrsCN¥691.00k12.71%
HK$ 10.0m
Guijin Liu
CFO & Executive Directorno datasin datossin datos
Haidong Jiang
Chief Technology Officerno datasin datossin datos
Luyang Zhao
VP of Human Resources & Joint Company Secretary5.2yrssin datossin datos
Siu Wai Tsoi
Joint Company Secretary3.1yrssin datossin datos

5.2yrs

Permanencia media

48yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de 2159 es experimentado (5.2 años antigüedad media).


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Wei Shi
Executive Chairman of the Board5.8yrsCN¥691.00k20.33%
HK$ 16.1m
Liang Wang
CEO & Executive Director5.2yrsCN¥691.00k6.02%
HK$ 4.8m
Weimin Yang
Executive Vice Chairman of the Board5.2yrsCN¥691.00k12.71%
HK$ 10.0m
Guijin Liu
CFO & Executive Directorless than a yearsin datossin datos
Ruilin Song
Independent Non-Executive Director3.9yrsCN¥321.00ksin datos
Zheng Wang
Independent Non-Executive Director3.9yrsCN¥229.00ksin datos
Xiaoxi Yang
Independent Non-Executive Director3.9yrsCN¥227.00ksin datos
Xia Liu
Non-Executive Director5.2yrssin datossin datos

4.5yrs

Permanencia media

48yo

Promedio de edad

Junta con experiencia: La junta directiva de 2159 se considera experimentada (4.5 años de antigüedad promedio).